Article
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.
Alimentary pharmacology & therapeutics - 1 Apr 2015
Sterling R K, Kuo A, Rustgi V K, Sulkowski M S, Stewart T G, Fenkel J M, El-Genaidi H, Mah'moud M A, Abraham G M, Stewart P W, Akushevich L, Nelson D R, Fried M W, Di Bisceglie A M
Abstract excerpt
BACKGROUND: HCV-TARGET is a longitudinal observational study of chronic hepatitis C virus (HCV) patients treated with direct-acting anti-viral agents (DAAs) in a US consortium of 90 academic and community medical centres. AIM: To assess utilisation of response-guided therapy (RGT) and sustained virological response (SVR) of a large cohort of patients. METHODS: Patients received peginterferon (PEG-IFN), ribavirin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.